Japan, Jan. 20 -- REGENERON PHARMACEUTICALS INC has got intellectual property rights for 'NON-HUMAN ANIMALS EXPRESSING EXOGENOUS TERMINAL DEOXYNUCLEOTIDYLTRANSFERASE.' Other related details are as follows:
Application Number: JP,2024-195337
Category (FI): C12N15/85,A01K67/0278,C12N15/12,C12N15/13,C12N15/54,C12N5/0783,C12N5/0735,C12N15/62@Z,C12N5/10
Stage: Grant (IP right granted following substantive examination.)
Filing Date: Nov. 7, 2024
Publication Date: Feb. 12, 2025
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
